MOG and myeloid sarcoma: Other studies, however, based separation of MOG autoantibody–positive patients from MS patients and HDs on serial dilutions; such studies showed that controls (n = 105) were positive for MOG autoantibodies at dilutions up to 1:640 (56, 57).